Relief For ‘Low T’? US FDA Eyes Literature-Based Expansion For Testosterone Therapy

 
• By Sue Sutter
  
NEJM
Published literature supports using testosterone therapy for low libido due to idiopathic hypogonadism, the FDA said. (Shutterstock)
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Approval Standards

More from United States